Exposure-oriented molecular profiling and machine learning prioritize the citrus flavonoid nobiletin as an antitumor candidate for colorectal cancer: integrated pharmacological evaluation

Colorectal cancer (CRC) remains a major health burden, and the pharmacologically relevant constituents of complex natural-product preparations are difficult to prioritize because chemical presence does not necessarily reflect systemic exposure. Here, we established an exposure-oriented pharmacological workflow integrating ultra-performance liquid chromatography–quadrupole time-of-flight tandem mass spectrometry (UPLC-QTOF-MS/MS) serum profiling, machine learning, public human CRC single-cell RNA sequencing, target integration, molecular modeling, and experimental evaluation to identify and characterize a prioritized bioactive candidate from Wumen Xianzhu Jiedu Decoction (WMXZJDD). Serum profiling after oral administration annotated 127 serum-exposure-related features, including 42 prototype components and 85 putative metabolites. After parent-compound mapping, deduplication, and structural filtering, 47 exposure-related parent compounds were retained for machine-learning prioritization. Nobiletin (NOB), a citrus-derived polymethoxylated flavonoid, ranked first according to the four-model composite prioritization score (0.77). Integrative analyses supported MAPK/JNK signaling as a candidate mechanism underlying NOB activity. NOB inhibited CT26 cell proliferation (24-h IC 50 , 70.8 μM) and reduced EdU incorporation, accompanied by increased JNK phosphorylation and upregulation of Beclin-1, ATG5, and NCOA4. In syngeneic CT26 tumor-bearing mice, NOB suppressed tumor growth without treatment-associated body-weight loss. These findings prioritize NOB as an anti-CRC candidate within an exposure-informed screening framework and illustrate the potential of integrating serum profiling, machine learning, and pharmacological evaluation for active-component discovery from complex natural-product preparations.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-12
DOI
https://doi.org/10.3389/fphar.2026.1976105
Primary Topic
Bioactive Compounds in Plants
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Exposure-oriented molecular profiling and machine learning prioritize the citrus flavonoid nobiletin as an antitumor candidate for colorectal cancer: integrated pharmacological evaluation

Yingqi Yang, Zhiyang Chen, Jiacheng Li, Wang Xiaopeng et al.
Frontiers in Pharmacology
Bioactive Compounds in Plants
article

Exposure-oriented molecular profiling and machine learning prioritize the citrus flavonoid nobiletin as an antitumor candidate for colorectal cancer: integrated pharmacological evaluation

Yingqi Yang, Zhiyang Chen, Jiacheng Li, Wang Xiaopeng, Meiyao Chen, Ziwei Xiong, Sicheng Shen, Zhuoqun Zhu, Jiajia Wan, Chuyue Wang
article en

Abstract

Colorectal cancer (CRC) remains a major health burden, and the pharmacologically relevant constituents of complex natural-product preparations are difficult to prioritize because chemical presence does not necessarily reflect systemic exposure. Here, we established an exposure-oriented pharmacological workflow integrating ultra-performance liquid chromatography–quadrupole time-of-flight tandem mass spectrometry (UPLC-QTOF-MS/MS) serum profiling, machine learning, public human CRC single-cell RNA sequencing, target integration, molecular modeling, and experimental evaluation to identify and characterize a prioritized bioactive candidate from Wumen Xianzhu Jiedu Decoction (WMXZJDD). Serum profiling after oral administration annotated 127 serum-exposure-related features, including 42 prototype components and 85 putative metabolites. After parent-compound mapping, deduplication, and structural filtering, 47 exposure-related parent compounds were retained for machine-learning prioritization. Nobiletin (NOB), a citrus-derived polymethoxylated flavonoid, ranked first according to the four-model composite prioritization score (0.77). Integrative analyses supported MAPK/JNK signaling as a candidate mechanism underlying NOB activity. NOB inhibited CT26 cell proliferation (24-h IC 50 , 70.8 μM) and reduced EdU incorporation, accompanied by increased JNK phosphorylation and upregulation of Beclin-1, ATG5, and NCOA4. In syngeneic CT26 tumor-bearing mice, NOB suppressed tumor growth without treatment-associated body-weight loss. These findings prioritize NOB as an anti-CRC candidate within an exposure-informed screening framework and illustrate the potential of integrating serum profiling, machine learning, and pharmacological evaluation for active-component discovery from complex natural-product preparations.

Frontiers in PharmacologyVol. 17
Nanjing University of Chinese Medicine (CN), Suzhou Traditional Chinese Medicine Hospital (CN)
Nanjing University of Chinese Medicine
Good health and well-being
Bioactive Compounds in Plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon